Barbara Lorber

Barbara Lorber

Auto-generated profile, based on publicly available information

Barbara Lorber

John van Geest Centre for Brain Repair, University of Cambridge, Cambridge, CB2 0PY, UK

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 December 2013 in Biofabrication
Verified
Journal Article
Open access
PDF file
BLBarbara Lorber
Barbara Lorber
WHWen-Kai Hsiao
Wen-Kai Hsiao
IHIan M Hutchings
Ian M Hutchings
KMKeith R Martin
Keith R Martin
We have investigated whether inkjet printing technology can be extended to print cells of the adult rat central nervous system (CNS), retinal ganglion cells (RGC) and glia, and the effects on survival and growth of these cells in culture, which is an important step in the development of tissue grafts for regenerative medicine, and may aid in the cure of blindness. We observed that RGC and glia can be successfully printed using a piezoelectric printer. Whilst inkjet printing reduced the cell population due to sedimentation within the printing system, imaging of the printhead nozzle, which is the area where the cells experience the greatest shear stress and rate, confirmed that there was no evidence of destruction or even significant distortion of the cells during jet ejection and drop formation. Importantly, the viability of the cells was not affected by the printing process. When we cultured the same number of printed and non-printed RGC/glial cells, there was no significant difference in cell survival and RGC neurite outgrowth. In addition, use of a glial substrate significantly increased RGC neurite outgrowth, and this effect was retained when the cells had been printed. In conclusion, printing of RGC and glia using a piezoelectric printhead does not adversely affect viability and survival/growth of the cells in culture. Importantly, printed glial cells retain their growth-promoting properties when used as a substrate, opening new avenues for printed CNS grafts in regenerative medicine.

1 January 2012 in Neurobiology of Disease
Verified
Journal Article
Closed access
BLBarbara Lorber
Barbara Lorber
AGAlessandra Guidi
Alessandra Guidi
JFJames W Fawcett
James W Fawcett
KMKeith R. Martin
Keith R. Martin

6 June 2012 in BMC Neuroscience
Verified
Journal Article
Open access
PDF file
BLBarbara Lorber
Barbara Lorber
ATAlessia Tassoni
Alessia Tassoni
NBNatalie D Bull
Natalie D Bull
MMMarilita Moschos
Marilita Moschos
KMKeith R Martin
Keith R Martin
Background: We have previously shown that the slow Wallerian degeneration mutation, whilst delaying axonal degeneration after optic nerve crush, does not protect retinal ganglion cell (RGC) bodies in adult rats. To test the effects of a combination approach protecting both axons and cell bodies we performed combined optic nerve crush and lens injury, which results in both enhanced RGC survival as well as axon regeneration past the lesion site in wildtype animals. Results: As previously reported we found that the Wld S mutation does not protect RGC bodies after optic nerve crush alone. Surprisingly, we found that Wld S transgenic rats did not exhibit the enhanced RGC survival response after combined optic nerve crush and lens injury that was observed in wildtype rats. RGC axon regeneration past the optic nerve lesion site was, however, similar in Wld S and wildtypes. Furthermore, activation of retinal glia, previously shown to be associated with enhanced RGC survival and axon regeneration after optic nerve crush and lens injury, was unaffected in Wld S transgenic rats. Conclusions: RGC axon regeneration is similar between Wld S transgenic and wildtype rats, but Wld S transgenic rats do not exhibit enhanced RGC survival after combined optic nerve crush and lens injury suggesting that the neuroprotective effects of lens injury on RGC survival may be limited by the Wld S protein.